A landmark study of 60,000 patients has identified three key health threats that coeliac disease patients should discuss with their healthcare providers. First, patients face a 39% elevated mortality risk compared to the general population. Second, non-Hodgkin lymphoma risk increases dramatically to 2.38 times higher than controls. Third, cardiovascular disease risk rises by 27%, indicating a need for heightened attention to heart health.
These findings from Columbia University and Karolinska Institute researchers, published in The Lancet Regional Health – Americas, emphasize that comprehensive medical follow-up is essential for optimal patient outcomes. Healthcare providers managing coeliac disease patients should consider implementing enhanced surveillance protocols for cancer and cardiovascular complications. Patients are encouraged to maintain regular clinical appointments and discuss screening strategies with their physicians to mitigate these identified risks and improve long-term health outcomes.
Read the full article on GMJ Newsroom.
Was this article helpful?
